On the benefits of therapeutic drug monitoring for patients undergoing treatment with antipsychotic agents

Int Clin Psychopharmacol. 2023 Mar 1;38(2):121-122. doi: 10.1097/YIC.0000000000000446. Epub 2022 Dec 16.

Authors

Laura Mercolini¹, Michele Protti¹, Roberto Mandrioli²

Affiliations

¹ Research Group of Pharmaco-Toxicological Analysis (PTA Laboratory), Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum, University of Bologna, Bologna.
² Department for Life Quality Studies (QuVi), Alma Mater Studiorum, University of Bologna, Rimini Campus, Rimini, Italy.

PMID: 36719340
DOI: 10.1097/YIC.0000000000000446

No abstract available

MeSH terms

Antipsychotic Agents* / adverse effects
Drug Monitoring
Humans
Patients

Substances

Antipsychotic Agents